Condition: Medullary Thyroid Carcinoma
Interventions: Drug: 111In-CP04; Drug: 111In-CP04 with co-administration of gelofusine/gelaspan
Sponsors: Paola Anna Erba; Jagiellonian University Medical College; University Hospital Freiburg; Medical University Innsbruck; University Medical Centre Ljubljana; NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland; Erasmus Medical Center; INRASTES, NCSR Demokritos, Athens, Greece
Recruiting - verified August 2017
http://ift.tt/2uvinVL
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου